Global Brain Abscess Disease Diagnostics Market Research Report – Segmentation by Pathogen Type (Bacterial, Fungal, and Parasite); By Imaging Type (MRI (Magnetic Resonance Imaging), CT (Computed Tomography) Scan, and PET (Positron Emission Tomography) Scan); By End User (Hospitals and Clinics, Diagnostic Imaging Centers, and Others); Region – Size, Share, Growth Analysis |Forecast (2024 – 2030)
Published: 2024 - January
Report Code: IM-16069
Format:
Region: Global
Chapter 1. GLOBAL BRAIN SBSCESS DISEASE DIAGNOSTICS MARKET – Scope & Methodology
1.1. Market Segmentation
1.2. Scope, Assumptions & Limitations
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. GLOBAL BRAIN SBSCESS DISEASE DIAGNOSTICS MARKET – Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.2.1. Demand Side
2.2.2. Supply Side
2.4. Attractive Investment Propositions
2.5. COVID-19 Impact Analysis
Chapter 3. GLOBAL BRAIN SBSCESS DISEASE DIAGNOSTICS MARKET – Competition Scenario
3.1. Market Share Analysis & Company Benchmarking
3.2. Competitive Strategy & Development Scenario
3.3. Competitive Pricing Analysis
3.4. Supplier-Distributor Analysis
Chapter 4. GLOBAL BRAIN SBSCESS DISEASE DIAGNOSTICS MARKET - Entry Scenario
4.1. Regulatory Scenario
4.2. Case Studies – Key Start-ups
4.3. Customer Analysis
4.5. PESTLE Analysis
4.4. Porters Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. GLOBAL BRAIN SBSCESS DISEASE DIAGNOSTICS MARKET - Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. GLOBAL BRAIN SBSCESS DISEASE DIAGNOSTICS MARKET – By Raw Material
6.1. Bacterial
6.2. Fungal
6.3. Parasite
Chapter 7. GLOBAL BRAIN SBSCESS DISEASE DIAGNOSTICS MARKET – By Composition
7.1. MRI (Magnetic Resonance Imaging)
7.2. CT (Computed Tomography) Scan
7.3. PET (Positron Emission Tomography) Scan
Chapter 8. GLOBAL BRAIN SBSCESS DISEASE DIAGNOSTICS MARKET – By Application
8.1. Hospitals and Clinics
8.2. Diagnostic Imaging Centers
8.3. Others
Chapter 9. GLOBAL BRAIN SBSCESS DISEASE DIAGNOSTICS MARKET, By Geography – Market Size, Forecast, Trends & Insights
9.1. North America
9.1.1. By Country
9.1.1.1. U.S.A.
9.1.1.2. Canada
9.1.1.3. Mexico
9.1.2. By Pathoging Type
9.1.3. By Imaging type
9.1.4. By End User
9.1.5. Countries & Segments - Market Attractiveness Analysis
9.2. Europe
9.2.1. By Country
9.2.1.1. U.K.
9.2.1.2. Germany
9.2.1.3. France
9.2.1.4. Italy
9.2.1.5. Spain
9.2.1.6. Rest of Europe
9.2.2. By Pathogen Type
9.2.3. By Imaging Type
9.2.4. By End User
9.2.5. Countries & Segments - Market Attractiveness Analysis
9.3. Asia Pacific
9.3.2. By Country
9.3.2.2. China
9.3.2.2. Japan
9.3.2.3. South Korea
9.3.2.4. India
9.3.2.5. Australia & New Zealand
9.3.2.6. Rest of Asia-Pacific
9.3.2. By Pathogen Type
9.3.3. By Imaging Type
9.3.4. By End User
9.3.5. Countries & Segments - Market Attractiveness Analysis
9.4. South America
9.4.3. By Country
9.4.3.3. Brazil
9.4.3.2. Argentina
9.4.3.3. Colombia
9.4.3.4. Chile
9.4.3.5. Rest South America
9.4.2. By Pathogen Type
9.4.3. By Imaging Type
9.4.4. By End User
9.4.5. Countries & Segments - Market Attractiveness Analysis
9.5. Middle East & Africa
9.5.4. By Country
9.5.4.4. United Arab Emirates (UAE)
9.5.4.2. Saudi Arabia
9.5.4.3. Qatar
9.5.4.4. Israel
9.5.4.5. South Africa
9.5.4.6. Nigeria
9.5.4.7. Kenya
9.5.4.8. Egypt
9.5.4.9. Rest of MEA
9.5.2. By Pathogen Type
9.5.3. By Imaging Type
9.5.4. By End User
9.5.5. Countries & Segments - Market Attractiveness Analysis
Chapter 10. GLOBAL BRAIN SBSCESS DISEASE DIAGNOSTICS MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
10.1. GE Healthcare
10.2. Siemens Healthineers
10.3. Philips Healthcare
10.4. Canon Medical Systems Corporation
10.5. Thermo Fisher Scientific
10.6. Roche Diagnostics
10.7. Hitachi Healthcare
10.8. Fujifilm Medical Systems
10.9. Hologic, Inc.
10.10. Agilent Technologies
10.11. Carestream Health
10.12. Esaote
10.13. Shimadzu Corporation
10.14. Mindray
10.15. NeuroLogica Corporation
Download Sample
Choose License Type
2850
5250
4500
1800
Frequently Asked Questions
The global brain abscess disease diagnostics market was valued at USD 500 million in 2023 and is projected to reach a market size of USD 751.82 million by the end of 2030 growing at a CAGR of 6% over the forecast period, 2024-2030.
Technological advancements and the demand for early diagnosis are the main factors propelling the Global Brain Abscess Disease Diagnostics Market.
Based on Imaging Type, the Global Brain Abscess Disease Diagnostics Market is segmented into MRI (Magnetic Resonance Imaging), CT (Computed Tomography) Scan, and PET (Positron Emission Tomography) Scan.
North America is the most dominant region for the Global Brain Abscess Disease Diagnostics Market.
GE Healthcare, Siemens Healthineers, and Philips Healthcare are the key players operating in the Global Brain Abscess Disease Diagnostics Market.
